VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue3,047,5972,488,6521,702,1771,032,336
Cost of Revenue1,826,0151,439,7441,258,1501,120,434
Gross Profit1,221,5821,048,908444,027-88,098
Operating Expenses
Research Development----
Selling General and Administrative557,616496,079432,829376,575
Non Recurring----
Others----
Total Operating Expenses2,383,6311,935,8231,690,9791,497,009
Operating Income or Loss663,966552,82911,198-464,673
Income from Continuing Operations
Total Other Income/Expenses Net-63,725-568,518-78,564-93,127
Earnings Before Interest and Taxes663,966552,82911,198-464,673
Interest Expense-34,119-57,550-81,432-84,206
Income Before Tax600,241-15,689-67,366-557,800
Income Tax Expense-1,486,862-107,32416,66530,381
Minority Interest-13,727181,609153,661
Net Income From Continuing Ops2,087,10391,635-84,031-588,181
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income2,096,896263,484-112,052-556,334
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares2,096,395263,191-112,052-556,334